Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)

Plain-language summary

This study investigates the role of peripheral blood cells in the mechanisms underlying chronic myelomonocytic leukemia. It was designed for patients newly diagnosed or being treated in the clinical hematology departments of the participating centers. The study is being conducted without an assigned phase and is still recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire de Nice

Start date

11/5/2014

Estimated completion

11/5/2028

Countries

France

Related genes

Locations

• Nice, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients newly diagnosed or undergoing treatment in the Clinical Hematology department of the participating establishments

Exclusion Criteria:

* NA